SCHEMBL17478596

SCHEMBL17478596

O=C(c1ccccc1)N1C[C@H](O)C[C@@H]1C(O)c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 11/20 0.70
MAOB P27338 1/20 0.39
CHRNB2 P17787 2/20 0.38
CHRNB4 P30926 2/20 0.38
CHRNA3 P32297 2/20 0.38
CHRNA7 P36544 2/20 0.38
CHRNA4 P43681 2/20 0.38
ABCB1 P08183 1/20 0.38
PLA2G1B P04054 1/20 0.38
ATG4B Q9Y4P1 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17484854 1.00 PIK3CD (0.70) PIK3CDMAOBCHRNB2CHRNB4CHRNA3
SCHEMBL18837763 1.00 PIK3CD (0.70) PIK3CDMAOBCHRNB2CHRNB4CHRNA3
SCHEMBL17478595 1.00 PIK3CD (0.70) PIK3CDMAOBCHRNB2CHRNB4CHRNA3
SCHEMBL17479559 1.00 PIK3CD (0.70) PIK3CDMAOBCHRNB2CHRNB4CHRNA3
SCHEMBL17479511 0.91 PIK3CD (0.62) PIK3CD
SCHEMBL17478586 0.91 PIK3CD (0.62) PIK3CD
SCHEMBL18837802 0.91 PIK3CD (0.62) PIK3CD
SCHEMBL17478597 0.91 PIK3CD (0.62) PIK3CD
SCHEMBL17484861 0.91 PIK3CD (0.62) PIK3CD
SCHEMBL19711140 0.82 PIK3CD (1.00) PIK3CDABCB1PLA2G1BATG4BL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174886-A1 2-OXA-5-AZABICYCLO[2.2.1]HEPTAN-3-YL DERIVATIVES F. Hoffmann-La Roche AG (CH) 2017-06-07 EP disclosed
WO-2016016292-A1 2-OXA-5-AZABICYCLO[2.2.1]HEPTAN-3-YL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2016-02-04 WO disclosed
WO-2016015333-A1 2-OXA-5-AZABICYCLO [2.2.1] HEPTAN-3-YL DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2016-02-04 WO disclosed